ManTech Announces Financial Results for Fourth Quarter and Fiscal Year 2015
Feb 17, 2016 21:05 pm UTC| Business
Revenues: $402 million for the fourth quarter, $1.55 billion for the fiscal yearExiting 2015 with three quarters of consecutive revenue growthOperating Margin: 5.7% for the fourth quarter, 5.5% for the fiscal yearDiluted...
CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
Feb 17, 2016 21:05 pm UTC| Business
Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test VolumesConference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif., Feb. 17, 2016 --...
LDR Holding Corporation Reports Record Revenue for Fourth Quarter and Fiscal Year 2015
Feb 17, 2016 21:05 pm UTC| Business
AUSTIN, Texas, Feb. 17, 2016 -- LDR Holding Corporation (NASDAQ:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients...
SharpSpring Reports Record Fourth Quarter and Full Year 2015 Results
Feb 17, 2016 21:05 pm UTC| Business
GAINESVILLE, Fla., Feb. 17, 2016 -- SharpSpring, Inc. (NASDAQ:SHSP), a global provider of cloud-based marketing technologies, reported its financial results for the fourth quarter and full year ended December 31, 2015. ...
AutoZone Announces Five-Year Agreement With JD Byrider
Feb 17, 2016 21:05 pm UTC| Business
MEMPHIS, Tenn., Feb. 17, 2016 -- AutoZone, Inc. (NYSE:AZO) is pleased to announce a five-year supplier agreement with JD Byrider, making AutoZone the preferred vendor and “first call” for parts at JD Byrider’s 170...
Denny’s Corporation Reports Results for Fourth Quarter and Full Year 2015
Feb 17, 2016 21:05 pm UTC| Business
- 5.8% Increase in 2015 Full Year Domestic System-Wide Same-Store Sales - - 16.4% Growth in 2015 Full Year Adjusted Net Income Per Share* - SPARTANBURG, S.C., Feb. 17, 2016 -- Denny’s Corporation (NASDAQ:DENN),...
Feb 17, 2016 21:05 pm UTC| Business
CAMBRIDGE, Mass., Feb. 17, 2016 -- Sage Therapeutics(NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, today announced that the...